X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (229) 229
index medicus (188) 188
female (153) 153
mutation (128) 128
oncology (123) 123
article (113) 113
genetic predisposition to disease (105) 105
breast cancer (103) 103
cancer (95) 95
breast neoplasms - genetics (91) 91
risk factors (82) 82
adult (81) 81
middle aged (77) 77
genetics & heredity (75) 75
medicin och hälsovetenskap (70) 70
medical and health sciences (69) 69
male (65) 65
genetic aspects (63) 63
polymorphism, single nucleotide (62) 62
research (59) 59
skin and connective tissue diseases (55) 55
risk (51) 51
cancer och onkologi (49) 49
cancer and oncology (48) 48
klinisk medicin (48) 48
clinical medicine (47) 47
genome-wide association (46) 46
ovarian cancer (45) 45
aged (44) 44
endocrine system diseases (43) 43
genes (42) 42
genes, brca1 (42) 42
heterozygote (41) 41
genes, brca2 (39) 39
genotype (39) 39
alleles (38) 38
brca1 protein - genetics (38) 38
genetics (38) 38
health aspects (38) 38
brca1 protein (37) 37
ovarian neoplasms - genetics (37) 37
brca2 protein (35) 35
genome-wide association study (34) 34
melanoma (34) 34
ovarian-cancer (32) 32
tumors (32) 32
expression (31) 31
gene mutations (31) 31
case-control studies (30) 30
population (30) 30
brca1 (29) 29
genomics (29) 29
brca2 protein - genetics (27) 27
genomes (27) 27
animals (24) 24
biochemistry & molecular biology (24) 24
brca2 (24) 24
cell biology (24) 24
cell line, tumor (24) 24
genetic variation (24) 24
medicine (24) 24
mutations (24) 24
breast neoplasms (23) 23
breast neoplasms - pathology (23) 23
melanoma - genetics (23) 23
germline mutations (21) 21
melanoma - drug therapy (21) 21
melanoma - pathology (21) 21
oncology, experimental (21) 21
breast-cancer (20) 20
breast (19) 19
germ-line mutation (19) 19
multidisciplinary sciences (19) 19
young adult (19) 19
braf (18) 18
common variants (18) 18
genetic predisposition to disease - genetics (18) 18
medical genetics (18) 18
mutation - genetics (18) 18
polymorphism (18) 18
susceptibility loci (18) 18
aged, 80 and over (17) 17
analysis (17) 17
carriers (17) 17
gene expression (17) 17
medical research (17) 17
mice (17) 17
single-nucleotide polymorphism (17) 17
susceptibility (17) 17
testicular neoplasms - genetics (17) 17
association (16) 16
genetic research (16) 16
health risk assessment (16) 16
life sciences (16) 16
linkage disequilibrium (16) 16
neoplasms (16) 16
proto-oncogene proteins b-raf - genetics (16) 16
adolescent (15) 15
breast neoplasms - metabolism (15) 15
càncer de mama (15) 15
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


New England Journal of Medicine, ISSN 0028-4793, 09/2006, Volume 355, Issue 13, pp. 1306 - 1356
Journal Article
NATURE MEDICINE, ISSN 1078-8956, 09/2013, Volume 19, Issue 9, pp. 1098 - 1100
The field of tumor immunology has been flooded with exciting therapeutic advances on many fronts. Immunotherapies targeting T cell inhibitory molecules have... 
MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNOTHERAPY | MUTANOME | BIOCHEMISTRY & MOLECULAR BIOLOGY | VACCINATION | ANTIGENS | CELL BIOLOGY | Cancer vaccines | Prognosis | Physiological aspects | T cells | Drug therapy | Health aspects | Tumors
Journal Article
Nature Medicine, ISSN 1078-8956, 09/2013, Volume 19, Issue 9, pp. 1098 - 1100
  The field of tumor immunology has been flooded with exciting therapeutic advances on many fronts. Immunotherapies targeting T cell inhibitory molecules have... 
Antibodies, Monoclonal, Humanized | Cancer Vaccines - immunology | Immunotherapy - methods | Antigens, Neoplasm - immunology | Melanoma - immunology | Humans | Antibodies, Monoclonal - therapeutic use | Melanoma - therapy | Precision Medicine - methods | Biomedical research | Vaccines | Genomics | Cancer
Journal Article
Journal Article
Nature, ISSN 0028-0836, 06/2017, Volume 546, Issue 7658, pp. 431 - 435
Therapies that target signalling molecules that are mutated in cancers can often have substantial short-term effects, but the emergence of resistant cancer... 
METASTATIC MELANOMA | BRAF INHIBITOR | SUBPOPULATIONS | CHROMATIN | MULTIDISCIPLINARY SCIENCES | SINGLE MAMMALIAN-CELLS | STATE | MECHANISMS | MUTATIONS | VEMURAFENIB | PLASTICITY | Transcription, Genetic - drug effects | Humans | Male | Transcription Factor AP-1 - metabolism | DNA-Binding Proteins - metabolism | Melanoma - genetics | Female | Indoles - pharmacology | Epigenesis, Genetic - drug effects | Gene Expression Regulation, Neoplastic - drug effects | SOXE Transcription Factors - deficiency | Single-Cell Analysis | Cellular Reprogramming - genetics | ErbB Receptors - metabolism | In Situ Hybridization, Fluorescence | Nuclear Proteins - metabolism | Signal Transduction - genetics | Melanoma - pathology | Sulfonamides - pharmacology | Cellular Reprogramming - drug effects | Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Genetic Markers - drug effects | Vemurafenib | Drug Resistance, Neoplasm - genetics | Animals | Signal Transduction - drug effects | Genetic Markers - genetics | Cell Line, Tumor | Oncogene Protein p65(gag-jun) - metabolism | Drug Resistance, Neoplasm - drug effects | SOXE Transcription Factors - genetics | Antimitotic agents | Cell interaction | Dosage and administration | Antineoplastic agents | Drug resistance | Observations | Health aspects | Subpopulations | Transcription factors | Substance abuse treatment | Variability | Activator protein 1 | Melanoma | Genomes | Kinases | Gene expression | Sox10 protein | Signal transduction | Signaling | Converting | Population | Mutation | Differentiation | Deoxyribonucleic acid--DNA | Cancer
Journal Article